ES8401474A1 - N-Phenalkyl:aminoalkyl-3-benzazepine derivs. - Google Patents

N-Phenalkyl:aminoalkyl-3-benzazepine derivs.

Info

Publication number
ES8401474A1
ES8401474A1 ES517760A ES517760A ES8401474A1 ES 8401474 A1 ES8401474 A1 ES 8401474A1 ES 517760 A ES517760 A ES 517760A ES 517760 A ES517760 A ES 517760A ES 8401474 A1 ES8401474 A1 ES 8401474A1
Authority
ES
Spain
Prior art keywords
group
alkyl
carbon atoms
hydroxy
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES517760A
Other languages
Spanish (es)
Other versions
ES517760A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Priority to ES517760A priority Critical patent/ES8401474A1/en
Publication of ES517760A0 publication Critical patent/ES517760A0/en
Publication of ES8401474A1 publication Critical patent/ES8401474A1/en
Expired legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

EP--65229 A Benzazepine derivs. of formula (I) and their addition salts are new: (A is CH2CH2, CH:CH, NHCO, CH2CO or CR7:N (NH, CH2 or CR7 being at 5 position), and B is then methylene or carbonyl, or A is COCO and B is then methylene. E is ethylene, n-propylene, or n-butylene, opt. substd. by a 1-3C alkyl or is 2-hydroxy substd. n-propylene or 2- or 3-hydroxy substd. n-butylene G is methylene or ethylene opt. substd. by a 1-3C alkyl. R1 and R2 are hydroxy, 1-3C alkyl or alkoxy, phenyl (1-3C)alkoxy, one of them can also be H, or R1 and R2 are together 1-2C alkylenedioxy. R3 and R4 are H, halo, hydroxy, 1-4C alkyl or alkoxy, trifluoro methyl or cyano, one of them can also be nitro, or R3 and R4 are together 1-2C alkylenedioxy. R5 is H, alkyl, hydroxy, alkoxy, amino (opt. substd. by 1 or 2 alkyl, by one alkanoyl, or by 1 or 2 alkoxycarbonyl) all alkyl having 1-3C, or is a methylamino or ethylamino gp. substd. by trifluoromethyl. R6 is H, alkyl, phenalkyl, alkanoyl or alkoxycarbonyl, (all alkyl 1-3C) or 3-5C alkenyl. R7 is 1-3C alkyl). They are made e.g. by reacting N-H benzazepines with Z.E.N(R6)G- substd. benzenes (Z is a leaving gp.). - (I) reduce the frequency and oxygen-demand of the heart, and have a long-lasting effect with reduced side effects (esp. low antimuscarinic effect), so are useful for treating sinus tachycardia and for preventing or treating ischaemic heart disorders. The only cpd. treated has intravenous and oral LD50's in mice 89-1350 mg per kg, respectively. EPAB- EP--65229 B Benzazepine derivs. of formula (I) and their addition salts are new: (A is CH2CH2, CH:CH, NHCO, CH2CO or CR7:N (NH, CH2 or CR7 being at 5 position), and B is then methylene or carbonyl, or A is COCO and B is then methylene. E is ethylene, n-propylene, or n-butylene, opt. substd. by a 1-3C alkyl or is 2-hydroxy substd. n-propylene or 2- or 3-hydroxy substd. n-butylene G is methylene or ethylene opt. substd. by a 1-3C alkyl. R1 and R2 are hydroxy, 1-3C alkyl or alkoxy, phenyl (1-3C)alkoxy, one of them can also be H, or R1 and R2 are together 1-2C alkylenedioxy. R3 and R4 are H, halo, hydroxy, 1-4C alkyl or alkoxy, trifluoro methyl or cyano, one of them can also be nitro, or R3 and R4 are together 1-2C alkylenedioxy. R5 is H, alkyl, hydroxy, alkoxy, amino (opt. substd. by 1 or 2 alkyl, by one alkanoyl, or by 1 or 2 alkoxycarbonyl) all alkyl having 1-3C, or is a methylamino or ethylamino gp. substd. by trifluoromethyl. R6 is H, alkyl, phenalkyl, alkanoyl or alkoxycarbonyl, (all alkyl 1-3C) or 3-5C alkenyl. R7 is 1-3C alkyl). They are made e.g. by reacting N-H benzazepines with Z.E.N(R6)G- substd. benzenes (Z is a leaving gp.). - (I) reduce the frequency and oxygen-demand of the heart, and have a long-lasting effect with reduced side effects (esp. low antimuscarinic effect), so are useful for treating sinus tachycardia and for preventing or treating ischaemic heart disorders. The only cpd. treated has intravenous and oral LD50's in mice 89-1350 mg per kg, respectively. (135pp) - EP--65229 B Benzazepine derivatives of general formula (1) wherein A represents a -CH2-CH2-, -CH=CH-, -NH-CO-, -CH2-CO- or -CR7=N-group wherein R7 represents an alkyl group containing 1 to 3 carbon atoms, and B represents a methylene or carbonyl group or A represents a -CO-CO group and B represents a methylene group. E represents an ethylene, n-propylene or n-butylene group optionally substituted by an alkyl group containing 1 to 3 carbon atoms, an n-propylene group substituted by a hydroxy group in the 2 position or an n-butylene group substituted by a hydroxy group in the 2 or 3 position, G represents a methylene or ethylene group optionally substituted by an alkyl group with 1 to 3 catbon atoms, R1 and R2, which may be the same or different, represent hydroxy groups, alkyl, alkoxy or phenylalkoxy groups wherein the alkyl part may contain 1 to 3 carbon atoms, or one of the groups R1 or R2 may also represent a hydrogen atom or R1 together with R2 may represent an alkylenedioxy group with 1 or 2 carbon atoms, R3 and R4, which may be the same or different, represent hydrogen or halogen atoms, hydroxy groups, alkyl or alkoxy groups each having 1 to 4 carbon atoms, trifluoromethyl or cyano groups or one of the groups R3 or R4 may also represent a nitro group or R3 together with R4 may represent an alkylenedioxy group with 1 or 2 carbon atoms, R5 represents a hydrogen atom, an alkyl, hydroxy, alkoxy, amino, alkylamino, dialkylamino, alkanoylamino, alkoxycarbonylamino or bis(alkoxycarbonyl)amino group wherein the alkyl part may contain 1 to 3 carbon atoms, or a methylamino or ethylamino group substituted by a trifluoromethyl group, and R6 represents a hydrogen atom, an alkyl, phenylalkyl, alkanoyl or alkoxycarbonyl group wherein the alkyl part may contain from 1 to 3 carbon atoms, or an alkenyl group with 3 to 5 carbon atoms, and the addition salts thereof, particularly the physiologically acceptable acid addition salts thereof with inorganic or organic acids. (81pp) GBAB- GB2099425 B Compounds of general formula (I) (wherein A represents a group of formula -CH2-CH2-, -CH=CH-, -NH-CO-, -CH2-CO- or CR7-N- (wherein R7 represents an alkyl group containing 1 to 3 carbon atoms) and B represents a methylene or carbonyl group, or A represents a -CO-CO- group and B represents a methylene group; E represents an ethylene, n-propylene or n-butylene group (optionally substituted by an alkyl group containing 1 to 3 carbon atoms), an n-propylene group substituted at the 2-position by a hydroxy group or n-butylene group substituted at the 2- or 3-position by a hydroxy group; G represents a methylene or ethylene group (optionally substituted by an alkyl group containing 1 to 3 carbon atoms); R1 and R2, which may be the same or different, each represents a hydroxy group, an alkyl group containing 1 to 3 carbon atoms, or an alkoxy or phenylalkoxy group (in each of which the alkyl part may contain 1 to 3 carbon atoms) or one of the radicals R1 and R2 represents a hydrogen atom or R1 together with R2 represents an alkylenedioxy group containing 1 or 2 carbon atoms; R3 and R4 which may be the same or different, each represents a hydrogen or halogen atom, a hydroxy group, an alkyl or alkoxy group, each of which may contain 1 to 4 carbon atoms, or a trifluoromethyl or cyano group or one of the radicals R3 or R4 represents a nitro group or R3 together with R4 represents an alkylenedioxy group containing 1 or 2 carbon atoms; R5 represents a hydrogen atom, a hydroxy or amino group, an alkyl, alkoxy or alkylamino group containing 1 to 3 carbon atoms or a dialkylamino, alkanoylamino, alkoxycarbonylamino or bis(alkoxycarbonyl)amino group, in each of which the alkyl part may contain from 1 to 3 carbon atoms, or a methylamino or ethylamino group substituted by a trifluoromethyl group; and R6 represents a hydrogen atom, an alkyl group containing from 1 to 3 carbon atoms, or a phenylalkyl, alkanoyl or alkoxycarbonyl group, in each of which the alkyl part may contain from 1 to 3l - GB2099425 B Compounds of general formula (I) (wherein A represents a group of formula -CH2-CH2-, -CH =CH-, -NH-CO-, -CH2-CO- or CR7-N- (wherein R7 represents an alkyl group containing 1 to 3 carbon atoms) and B represents a methylene or carbonyl group, or A represents a -CO-CO- group and B represents a methylene group; E represents an ethylene, n-propylene or n-butylene group (optionally substituted by an alkyl group containing 1 to 3 carbon atoms), an n-propylene group substituted at the 2-position by a hydroxy group or n-butylene group substituted at the 2- or 3-position by a hydroxy group; G represents a methylene or ethylene group (optionally substituted by an alkyl group containing 1 to 3 carbon atoms); R1 and R2, which may be the same or different, each represents a hydroxy group, an alkyl group containing 1 to 3 carbon atoms, or an alkoxy or phenylalkoxy group (in each of which the alkyl part may contain 1 to 3 carbon atoms) or one of the radicals R1 and R2 represents a hydrogen atom or R1 together with R2 represents an alkylenedioxy group containing 1 or 2 carbon atoms; R3 and R4 which may be the same or different, each represents a hydrogen or halogen atom, a hydroxy group, an alkyl or alkoxy group, each of which may contain 1 to 4 carbon atoms, or a trifluoromethyl or cyano group or one of the radicals R3 or R4 represents a nitro group or R3 together with R4 represents an alkylenedioxy group containing 1 or 2 carbon atoms; R5 represents a hydrogen atom, a hydroxy or amino group, an alkyl, alkoxy or alkylamino group containing 1 to 3 carbon atoms or a dialkylamino, alkanoylamino, alkoxycarbonylamino or bis(alkoxycarbonyl)amino group, in each of which the alkyl part may contain from 1 to 3 carbon atoms, or a methylamino or ethylamino group substituted by a trifluoromethyl group; and R6 represents a hydrogen atom, an alkyl group containing from 1 to 3 carbon atoms, or a phenylalkyl, alkanoyl or alkoxycarbonyl group, in each of which the alkyl part may contain from 1 to 3
ES517760A 1982-11-29 1982-11-29 N-Phenalkyl:aminoalkyl-3-benzazepine derivs. Expired ES8401474A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES517760A ES8401474A1 (en) 1982-11-29 1982-11-29 N-Phenalkyl:aminoalkyl-3-benzazepine derivs.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES517760A ES8401474A1 (en) 1982-11-29 1982-11-29 N-Phenalkyl:aminoalkyl-3-benzazepine derivs.

Publications (2)

Publication Number Publication Date
ES517760A0 ES517760A0 (en) 1983-12-16
ES8401474A1 true ES8401474A1 (en) 1983-12-16

Family

ID=8484993

Family Applications (1)

Application Number Title Priority Date Filing Date
ES517760A Expired ES8401474A1 (en) 1982-11-29 1982-11-29 N-Phenalkyl:aminoalkyl-3-benzazepine derivs.

Country Status (1)

Country Link
ES (1) ES8401474A1 (en)

Also Published As

Publication number Publication date
ES517760A0 (en) 1983-12-16

Similar Documents

Publication Publication Date Title
FI901447A0 (en) Process for the preparation of pharmacologically active 8-substituted xanthine derivatives
NZ336202A (en) Pure enantiomer aryl-cycloalkyl-hydroxycarboxylic acid esters and use in treating smooth muscle spasms and respiritory diseases
SE8004002L (en) THERAPEUTICALLY APPLICABLE TETRALIN DERIVATIVES
TW377352B (en) Pyrido[2,3-d]pyrimidine derivatives and pharmaceutical compositions thereof
PT96946A (en) AZABICYCLE AND OXYME AND AZINIC ACID PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2703050B1 (en) New nitrogenous bicyclic derivatives, process for their preparation and the pharmaceutical compositions containing them.
TW429255B (en) Pyrazine compounds having treatment of central nervous system diseases and disorders
IE883048L (en) Polyamine derivatives as antineoplastic agents
HU9202618D0 (en) Benzazepine compounds having therapeutical effect
BG105855A (en) 2-aminopyridines containing fused ring substituents
ES8401471A1 (en) N-Phenalkyl:aminoalkyl-3-benzazepine derivs.
ES8401473A1 (en) N-Phenalkyl:aminoalkyl-3-benzazepine derivs.
ES8401472A1 (en) N-Phenalkyl:aminoalkyl-3-benzazepine derivs.
ES8401474A1 (en) N-Phenalkyl:aminoalkyl-3-benzazepine derivs.
GR871549B (en) Amino acid derivative anticonvulsant
EE9800225A (en) Condensed 2,3-benzodiazepine derivatives and their use for the inhibition of AMPA receptors
DE3267291D1 (en) Heteroarylpropanol amines, process for preparing them and medicines containing these compounds
FR2633292B1 (en) NOVEL 20,21-DINOREBURNAMENINE DERIVATIVES SUBSTITUTED IN 15 BY AN AMINE GROUP, THEIR PREPARATION METHOD AND THE INTERMEDIATES THUS OBTAINED, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE69225381D1 (en) Nootropic active ingredients
MY108455A (en) Therapeutic benzazapine compounds.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20031006